Tianjin Lisheng Pharmaceutical announced that the company's pharmaceuticals, Sildenafil Slow-release Tablets 1.5mg, have been granted market approval by the National Medical Products Administration for the treatment of primary hypertension in adults.
力生制药：吲达帕胺缓释片通过上市许可申请
Tianjin Lisheng Pharmaceutical: The approval application for Indapamide sustained-release tablets has been granted.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.